Skip to main content
Công ty Cổ phần Dược phẩm Bến Tre logo

Công ty Cổ phần Dược phẩm Bến Tre — Investor Relations & Filings

Ticker · DBT ISIN · VN000000DBT6 HSX Manufacturing
Open in API
Filings indexed 425 across all filing types
Latest filing 2024-06-28 Share Issue/Capital Cha…
Country VN Viet Nam
Listing HSX DBT

About Công ty Cổ phần Dược phẩm Bến Tre

www.bepharco.com

Bepharco (Công ty Cổ phần Dược phẩm Bến Tre) is a pharmaceutical company established in 1963, with over 60 years of experience in the production and distribution of pharmaceutical products. The company specializes in a diverse range of offerings, including prescription drugs, health protection foods, and medical equipment. Key product areas include cardiovascular, digestive, and anti-allergy medications, as well as traditional medicine. Bepharco maintains an extensive distribution network across numerous provinces and cities, and exports its products globally. It is recognized for its commitment to quality and its strategic collaborations in pharmaceutical education and research.

Recent filings

Filing Released Lang Actions
DBT: Thông báo về ngày ĐKCC phát hành cổ phiếu để trả cổ tức năm 2023
Share Issue/Capital Change Classification · 87% confidence The document is an official stock exchange announcement from the Ho Chi Minh City Stock Exchange setting out the ex-rights date and record date for a stock dividend issuance (issuing new shares to pay 2023 dividends at a ratio of 100:14). It details the share issue mechanics, rounding rules, and collection procedures. This clearly falls under “Share Issue/Capital Change” (announcements of new share issues/capital changes).
2024-06-28 Vietnamese
DBT: CBTT Nghị quyết HĐQT thông qua giải thế phòng Trade Marketing
Regulatory Filings Classification · 80% confidence The document is a corporate announcement (“CÔNG BỐ THÔNG TIN BẤT THƯỜNG”) filed with the State Securities Commission and the Ho Chi Minh Stock Exchange. It contains a Board resolution to dissolve the Trade Marketing department and update the organizational chart. There is no financial data or report attached, nor is it an annual or interim report. It does not fit any specialized categories (e.g., board membership changes, dividends, M&A, proxy materials), so it defaults to a general regulatory announcement. Under our taxonomy, that maps to “Regulatory Filings (RNS).”
2024-06-28 Vietnamese
DBT: CBTT Nghị quyết HĐQT thông qua bán cổ phiếu CTCP Dược phẩm Yên Bái
Regulatory Filings Classification · 75% confidence The document is a Vietnamese regulatory announcement (“Công bố thông tin bất thường”) by Bepharco, notifying the State Securities Commission and HoSE of a board‐approved sale of shares in another company (Yên Bái Pharma). It is not a financial report (10‐K/IR), not a director insider trade (DIRS), not a dividend, proxy, M&A or ESG report. It is a general regulatory disclosure of a board resolution and transaction. There is no specific category for a sale of an investment other than a catch‐all regulatory filing. Therefore it best fits the fallback “Regulatory Filings” (RNS).
2024-06-24 Vietnamese
DBT: Thông báo phát hành cổ phiếu để trả cổ tức năm 2023
Share Issue/Capital Change Classification · 95% confidence The document is a Vietnamese corporate announcement titled “Thông báo phát hành cổ phiếu để trả cổ tức năm 2023,” detailing the plan and terms to issue additional ordinary shares as dividend payment (including number of shares, rights ratio, record date, funding source, etc.). This clearly describes a share issuance and capital change rather than a financial report or dividend cash notice. According to the classification list, this falls under Share Issue/Capital Change (SHA).
2024-06-24 Vietnamese
DBT: Thông báo về ngày ĐKCC thực hiện quyền nhận cổ phiếu phát hành để trả cổ tức năm 2023
Share Issue/Capital Change Classification · 85% confidence The document is a formal notification by Bepharco Joint Stock Company to securities regulators and the central depository, announcing the record date (08/07/2024) and detailed terms (ratio 100:14) for issuing new shares to pay the 2023 dividend. It specifies the share issue, capital increase mechanism, and record date for shareholders. This fits the definition of a Share Issue/Capital Change announcement (new share issuance for dividend distribution).
2024-06-24 Vietnamese
DBT: Nghị quyết HĐQT về ngày ĐKCC thực hiện quyền nhận cổ tức bằng cổ phiếu năm 2023
Share Issue/Capital Change Classification · 88% confidence The document is a Board of Directors resolution setting the record date, issuance ratio, and procedures for issuing new shares as a stock dividend for 2023. This constitutes an announcement of a new share issue/capital change (stock dividend issuance). It is not a dividend cash payment notice but specifically a share issuance, fitting the Share Issue/Capital Change category.
2024-06-21 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.